
Press Releases
Press Release
NanoString to Present at the 38th Annual JP Morgan Healthcare Conference
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that the company’s management is scheduled to present at the 38th Annual…
Press Release
NanoString Announces the Creation of the GeoMx Breast Cancer Consortium
Consortium Plans to Apply Spatial Analysis to Major Challenges in Breast Cancer Research SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today…
Press Release
Nature Medicine Publication Highlights Use of NanoString’s Hyb & Seq Technology to Perform Rapid Genotypic and Phenotypic Antibiotic Susceptibility Testing
Technology for Rapid Pathogen Identification and Phenotypic Antibiotic Susceptibility, Licensed from Broad Institute, Enables Testing Across a Wide Range of Pathogens SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider…
Press Release
NanoString Announces Exclusive License of nCounter Diagnostic Assets and Rights to Veracyte
Creates Potential for Significantly Expanded Test Menu Sharpens NanoString’s Strategic Focus on Rapidly Growing Research Business Including Recent Launch of GeoMx Digital Spatial Profiler Strengthens Financial Profile through Capital Infusion…
Press Release
NanoString to Present at the Evercore ISI 2nd Annual HealthCONx Conference
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present…
Press Release
NanoString to Present at the Stifel 2019 Healthcare Conference
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present…
Press Release
NanoString Highlights the Results of Research Presented at the 2019 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
Presentations Include Data from More than Thirty NanoString-Related Abstracts Including Five Using the GeoMx Digital Spatial Profiler SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools…
Press Release
NanoString Announces Availability of the GeoMx Cancer Transcriptome Atlas Through the Technology Access Program for Digital Spatial Profiling
Spatial Analysis of More Than 1,600 Key Cancer Genes from Fresh Frozen and Formalin-Fixed Paraffin-Embedded Tissue SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for…
Press Release
NanoString Technologies Supports the Human Cell Atlas (HCA) to Enable High-plex Spatial Analysis Across Discovery Programs
A Global Collaboration with 1000+ HCA Research Institutes SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that…
Press Release
NanoString Technologies Releases Operating Results for Third Quarter of 2019
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the third quarter of 2019. This…
Press Release
NanoString Appoints Don Kania, Ph.D. to its Board of Directors
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of Don Kania, Ph.D. to its…
Press Release
NanoString to Release Third Quarter 2019 Financial Results and Host Conference Call on Monday, November 4, 2019
SEATTLE--(BUSINESS WIRE)--Oct. 7, 2019-- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release third quarter…